Related Experiment Video
Updated: Aug 30, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Practical recommendations for the implementation of shared decision-making in multiple myeloma care
Jolien Broekmans1, Elise Schoefs1, Charlotte Verbeke1
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Background:
Multiple myeloma (MM) is characterized by complex and evolving treatment pathways, involving multiple preference-sensitive decisions across the disease trajectory. Shared decision-making (SDM) is widely recognized as a best-practice approach for such decisions, yet practical, context-specific guidance for implementing SDM in MM care remains limited.
Objective:
To develop a set of practical, stakeholder-informed recommendations to support the implementation of SDM in MM care.
Methods:
This study was conducted as part of a European mixed-methods research project initiated by the patient organization Myeloma Patients Europe. Building on empirical studies involving MM patients and healthcare professionals (HCPs), an initial set of 24 recommendations was developed. These recommendations were subsequently refined, and agreed upon through two online multi-stakeholder workshops, involving patients, carers, hematologists, oncology nurses, and patient organization representatives from multiple European countries. Qualitative workshop data were thematically analyzed, and recommendations were consolidated through iterative team discussions.
Results:
The final output comprises ten core recommendations addressing SDM implementation at multiple levels. Key themes included in the recommendations are adopting a personalized and preference-sensitive approach to patient involvement, tailoring information provision, openly discussing all treatment options including no treatment, strengthening multidisciplinary communication, supporting patient preparation and partnership, ensuring continuity of care, and providing structural, educational, and organizational support for SDM.
Conclusions:
These recommendations translate SDM principles into guiding considerations tailored to the specific challenges of MM care. They provide a foundation for context-sensitive implementation efforts aimed at strengthening patient-centered decision-making in MM.
Related Concept Videos
Ethical Dilemmas II
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Ethical Issues
Ethical Concerns in Healthcare: